Logo image of ACVA

ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis

NASDAQ:ACVA - Nasdaq - US00091G1040 - Common Stock - Currency: USD

21.36  +0.5 (+2.4%)

Fundamental Rating

3

Taking everything into account, ACVA scores 3 out of 10 in our fundamental rating. ACVA was compared to 84 industry peers in the Commercial Services & Supplies industry. While ACVA seems to be doing ok healthwise, there are quite some concerns on its profitability. ACVA is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ACVA has reported negative net income.
In the past year ACVA had a positive cash flow from operations.
ACVA had negative earnings in each of the past 5 years.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
ACVA Yearly Net Income VS EBIT VS OCF VS FCFACVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

ACVA's Return On Assets of -7.43% is on the low side compared to the rest of the industry. ACVA is outperformed by 75.61% of its industry peers.
With a Return On Equity value of -16.84%, ACVA is not doing good in the industry: 69.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.43%
ROE -16.84%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-12.55%
ROE(3y)-17.2%
ROE(5y)-21.46%
ROIC(3y)N/A
ROIC(5y)N/A
ACVA Yearly ROA, ROE, ROICACVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -10 -20 -30

1.3 Margins

ACVA has a Gross Margin of 51.48%. This is amongst the best in the industry. ACVA outperforms 90.24% of its industry peers.
ACVA's Gross Margin has improved in the last couple of years.
ACVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.47%
GM growth 5YN/A
ACVA Yearly Profit, Operating, Gross MarginsACVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

4

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACVA has more shares outstanding than it did 1 year ago.
ACVA has a worse debt/assets ratio than last year.
ACVA Yearly Shares OutstandingACVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
ACVA Yearly Total Debt VS Total AssetsACVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

ACVA has an Altman-Z score of 3.56. This indicates that ACVA is financially healthy and has little risk of bankruptcy at the moment.
ACVA has a better Altman-Z score (3.56) than 70.73% of its industry peers.
ACVA has a debt to FCF ratio of 13.50. This is a negative value and a sign of low solvency as ACVA would need 13.50 years to pay back of all of its debts.
ACVA's Debt to FCF ratio of 13.50 is in line compared to the rest of the industry. ACVA outperforms 48.78% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that ACVA is not too dependend on debt financing.
ACVA has a Debt to Equity ratio of 0.25. This is in the better half of the industry: ACVA outperforms 67.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 13.5
Altman-Z 3.56
ROIC/WACCN/A
WACC8.96%
ACVA Yearly LT Debt VS Equity VS FCFACVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

ACVA has a Current Ratio of 1.51. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
ACVA's Current ratio of 1.51 is in line compared to the rest of the industry. ACVA outperforms 47.56% of its industry peers.
A Quick Ratio of 1.51 indicates that ACVA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.51, ACVA is in the better half of the industry, outperforming 62.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
ACVA Yearly Current Assets VS Current LiabilitesACVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

7

3. Growth

3.1 Past

ACVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.95%.
ACVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.34%.
The Revenue has been growing by 32.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-17.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)29.34%
Revenue growth 3Y32.18%
Revenue growth 5YN/A
Sales Q2Q%43.96%

3.2 Future

The Earnings Per Share is expected to grow by 46.63% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACVA will show a very strong growth in Revenue. The Revenue will grow by 25.06% on average per year.
EPS Next Y-27.05%
EPS Next 2Y24.43%
EPS Next 3Y42.13%
EPS Next 5Y46.63%
Revenue Next Year31.67%
Revenue Next 2Y28.04%
Revenue Next 3Y28.5%
Revenue Next 5Y25.06%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ACVA Yearly Revenue VS EstimatesACVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ACVA Yearly EPS VS EstimatesACVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3 4 5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ACVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ACVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACVA Price Earnings VS Forward Price EarningsACVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ACVA is valued a bit more expensive than the industry average as 63.41% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 420.33
EV/EBITDA N/A
ACVA Per share dataACVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as ACVA's earnings are expected to grow with 42.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.43%
EPS Next 3Y42.13%

More info and screens

0

5. Dividend

5.1 Amount

ACVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACV AUCTIONS INC-A

NASDAQ:ACVA (2/5/2025, 10:39:38 AM)

21.36

+0.5 (+2.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners101.32%
Inst Owner Change0.41%
Ins Owners1.33%
Ins Owner Change-12.48%
Market Cap3.58B
Analysts82
Price Target25.28 (18.35%)
Short Float %5.97%
Short Ratio7.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.39%
Min EPS beat(2)8.37%
Max EPS beat(2)14.41%
EPS beat(4)3
Avg EPS beat(4)-0.14%
Min EPS beat(4)-30.72%
Max EPS beat(4)14.41%
EPS beat(8)7
Avg EPS beat(8)20.08%
EPS beat(12)10
Avg EPS beat(12)15.87%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.75%
Min Revenue beat(2)0.79%
Max Revenue beat(2)4.71%
Revenue beat(4)2
Avg Revenue beat(4)0.71%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)4.71%
Revenue beat(8)4
Avg Revenue beat(8)0.92%
Revenue beat(12)6
Avg Revenue beat(12)1.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.01%
PT rev (3m)7.76%
EPS NQ rev (1m)1.59%
EPS NQ rev (3m)-11.23%
EPS NY rev (1m)0.45%
EPS NY rev (3m)1.76%
Revenue NQ rev (1m)0.28%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)1.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.01
P/FCF 420.33
P/OCF 85.01
P/B 7.85
P/tB 31.66
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)0.05
FCFY0.24%
OCF(TTM)0.25
OCFY1.18%
SpS3.56
BVpS2.72
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.43%
ROE -16.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.48%
FCFM 1.43%
ROA(3y)-9.09%
ROA(5y)-12.55%
ROE(3y)-17.2%
ROE(5y)-21.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.47%
GM growth 5YN/A
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 13.5
Debt/EBITDA N/A
Cap/Depr 100.83%
Cap/Sales 5.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 3.56
F-Score5
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)170.68%
Cap/Depr(5y)198.6%
Cap/Sales(3y)5.11%
Cap/Sales(5y)5.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y-27.05%
EPS Next 2Y24.43%
EPS Next 3Y42.13%
EPS Next 5Y46.63%
Revenue 1Y (TTM)29.34%
Revenue growth 3Y32.18%
Revenue growth 5YN/A
Sales Q2Q%43.96%
Revenue Next Year31.67%
Revenue Next 2Y28.04%
Revenue Next 3Y28.5%
Revenue Next 5Y25.06%
EBIT growth 1Y11.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128.89%
EBIT Next 3Y59.77%
EBIT Next 5Y44.2%
FCF growth 1Y108.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y153.7%
OCF growth 3YN/A
OCF growth 5YN/A